CytomX Therapeutics (CTMX) PT Lowered to $3 at BMO Capital
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Price: $2.68 -2.55%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Join SI Premium – FREE
BMO Capital analyst Etzer Darout lowered the price target on CytomX Therapeutics (NASDAQ: CTMX) to $3.00 (from $9.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
- Akamai Technologies (AKAM) PT Raised to $158 at Piper Sandler Amid 'Record Anthropic Deal'
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
